In our analysis, we show reduced expression of 3-hydroxybutyrate dehydrogenase, type (BDH1), an important catalyst of ketone metabolism, in skeletal muscle of T2D (Table 2), which was significantly upregulated 1 year following RYGB (Table 3). Here, BDH1 is linked to type 2 diabetes mellitus.